Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Gustoeson May 10, 2019 9:31am

112 Views

Post# 29733460

RE:RE:RE:RE:Hey longs. Phase II News

enriquesuave wrote: Let’s hope we hear more news soon on enrolment and other trial sites. I’m sure a lot of patients at PMH have already been “prescreened” in anticipation of trial. So when it says Up To 28 days it could be a lot less as patients already in the hospital have their med histories already known. IMHO

Make sure to update your Inspire postings too. :)

Bullboard Posts

Changing Europe’s dependency on HREE from China